10-Q Filing

Xenetic Biosciences, Inc. CIK: 1534525 Q1 2021

Filing Information

Form Type	10-Q
Accession Number	`0001683168-21-001893`
Period End Date	20210331
Filing Date	20210511
Fiscal Year	2021
Fiscal Period	Q1
XBRL Instance	xbio-20200331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 50 Income Statement 22 Cash Flow Statement 28 Stockholders Equity 14

Balance Sheet 50 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	8.77M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	8.77M	shares	Point-in-time
Cash	`Cash`	$10.01M	USD	Point-in-time
Cash	`Cash`	$11.53M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	8.75M	shares	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$841.96K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	8.75M	shares	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$1.03M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$12.37M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$11.04M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$809.99K	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$725.51K	USD	Point-in-time
Total assets	`Assets`	$13.18M	USD	Point-in-time
Total assets	`Assets`	$11.76M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$207.81K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$327.40K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$609.53K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$590.38K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$798.19K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$936.93K	USD	Point-in-time
Other long-term liabilities	`LiabilitiesOtherThanLongtermDebtNoncurrent`	$17.57K	USD	Point-in-time
Other long-term liabilities	`LiabilitiesOtherThanLongtermDebtNoncurrent`	$27.04K	USD	Point-in-time
Total liabilities	`Liabilities`	$963.97K	USD	Point-in-time
Total liabilities	`Liabilities`	$815.76K	USD	Point-in-time
Commitments (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, 10,000,000 shares authorized	`PreferredStockValue`	$2.77K	USD	Point-in-time
Preferred stock, 10,000,000 shares authorized	`PreferredStockValue`	$2.77K	USD	Point-in-time
Common stock, $0.001 par value; 50,000,000 shares authorized as of March 31, 2021 and December 31, 2020; 8,773,683 and 8,772,198 shares issued as of March 31, 2021 and December 31, 2020, respectively; 8,746,692 and 8,745,207 shares outstanding as of March 31, 2021 and December 31, 2020, respectively	`CommonStockValue`	$8.77K	USD	Point-in-time
Common stock, $0.001 par value; 50,000,000 shares authorized as of March 31, 2021 and December 31, 2020; 8,773,683 and 8,772,198 shares issued as of March 31, 2021 and December 31, 2020, respectively; 8,746,692 and 8,745,207 shares outstanding as of March 31, 2021 and December 31, 2020, respectively	`CommonStockValue`	$8.77K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$194.21M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$194.13M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-178.25M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-176.90M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$253.73K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$253.73K	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$5.28M	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$5.28M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$10.95M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$17.21M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$16.20M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$12.22M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$11.76M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$13.18M	USD	Point-in-time

Income Statement 22 line items

Line Item	Tag	Value	Unit	Period
Total revenues	`Revenues`	$56.75K	USD	1 Quarter
Total revenues	`Revenues`	$191.22K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$629.73K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$359.65K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$930.58K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$927.88K	USD	1 Quarter
Total operating costs and expenses	`OperatingExpenses`	$1.56M	USD	1 Quarter
Total operating costs and expenses	`OperatingExpenses`	$1.29M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.23M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.37M	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-134.00	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$884.00	USD	1 Quarter
Interest income	`InterestIncomeExpenseNet`	$22.26K	USD	1 Quarter
Interest income	`InterestIncomeExpenseNet`	$51.49K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$23.15K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$51.35K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.18M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.35M	USD	1 Quarter
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-0.15	USD	1 Quarter
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-0.19	USD	1 Quarter
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	8.75M	shares	1 Quarter
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	6.23M	shares	1 Quarter

Cash Flow Statement 28 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-1.18M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.35M	USD	1 Quarter
Depreciation	`Depreciation`	-	USD	1 Quarter
Depreciation	`Depreciation`	$591.00	USD	1 Quarter
Amortization of right of use asset	`OtherDepreciationAndAmortization`	$8.41K	USD	1 Quarter
Amortization of right of use asset	`OtherDepreciationAndAmortization`	$6.82K	USD	1 Quarter
Share-based expense	`ShareBasedCompensation`	$165.60K	USD	1 Quarter
Share-based expense	`ShareBasedCompensation`	$76.28K	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInAccountsAndOtherReceivables`	$86.45K	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInAccountsAndOtherReceivables`	$109.73K	USD	1 Quarter
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-148.21K	USD	1 Quarter
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$92.14K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.52M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.00M	USD	1 Quarter
Net change in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-1.00M	USD	1 Quarter
Net change in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-1.52M	USD	1 Quarter
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$11.53M	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.37M	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.01M	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.37M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$11.53M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.37M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.01M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.37M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	-	USD	1 Quarter
Cash paid for interest	`InterestPaidNet`	-	USD	1 Quarter
Issuance of common stock from cashless exercise of purchase warrants	`IssuanceOfCommonStockFromCashlessExerciseOfPurchaseWarrants`	$1.00	USD	1 Quarter
Issuance of common stock from cashless exercise of purchase warrants	`IssuanceOfCommonStockFromCashlessExerciseOfPurchaseWarrants`	$219.00	USD	1 Quarter

Stockholders Equity 14 line items

Line Item	Tag	Value	Unit	Period
Beginning balance, value	`StockholdersEquity`	$10.95M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$17.21M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$16.20M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$12.22M	USD	Point-in-time
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$76.28K	USD	1 Quarter
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$165.60K	USD	1 Quarter
Exercise of purchase warrants, value	`ExerciseOfPurchaseWarrantsValue`	-	USD	1 Quarter
Exercise of purchase warrants, value	`ExerciseOfPurchaseWarrantsValue`	-	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.18M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.35M	USD	1 Quarter
Ending balance, value	`StockholdersEquity`	$10.95M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$17.21M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$16.20M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$12.22M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.